Latest Regulatory Progress News

OncoSil Medical’s PANCOSIL Phase 1-2 study reveals promising safety and feasibility for a novel CT-guided pancreatic cancer therapy, with survival outcomes exceeding historical benchmarks.

Medallion Metals has taken a crucial step forward by ordering a secondary ball mill to upgrade the Cosmic Boy Concentrator, underpinning its Sulphide Production Strategy and advancing its feasibility study toward a final investment decision.

Renergen Limited and ASP Isotopes Inc. have proactively extended the deadline to fulfill outstanding conditions for their Scheme of Arrangement offer to 28 November 2025, following key regulatory approvals and ongoing collaboration.

EVE Health Group has appointed Dr Fiona Cousins as the inaugural member of its Scientific Advisory Board, reinforcing its commitment to advancing treatments for dysmenorrhoea and endometriosis ahead of the commercial launch of Dyspro™.

St Barbara Limited has withdrawn its Supreme Court appeal over reclamation conditions at the Touquoy Mine, citing improved regulatory cooperation in Nova Scotia, and is now investigating reopening the mine to process 3.1 million tonnes of low and medium grade gold stockpiles.

New Frontier Minerals has appointed GeoDrill Australia to lead its inaugural drilling campaign at the Harts Range Project, targeting a suite of critical minerals vital to modern technologies and energy transition.

Lefroy Exploration is nearing operational readiness at its Lucky Strike Gold Deposit with key approvals and designs in place, while gearing up for a high-grade drilling campaign at Burns Central. The company is fully funded and poised for a self-funded growth phase.

Boab Metals has extended its option to acquire full ownership of the Sorby Hills Project to the end of 2025, while locking in critical commercial agreements and environmental approvals that pave the way for a final investment decision.

Thor Energy has signed a term sheet with DISA Technologies to explore processing abandoned uranium waste dumps in Colorado, aiming to generate revenue without upfront costs using innovative HPSA technology.

Southern Palladium has initiated a comprehensive drilling campaign at its Bengwenyama PGM project, marking a critical step toward completing its Definitive Feasibility Study in early 2026. The program aims to refine metallurgical data and mine design while regulatory approvals edge closer.

Osteopore Limited has established OsteoRx, a new special purpose vehicle, with an initial AUD 0.5 million investment to accelerate breakthroughs in cellular regenerative medicine. This strategic move integrates a controlling stake in US-based RxCell Inc, expanding Osteopore’s footprint in the fast-growing stem cell market.

Argent BioPharma reported a net loss of A$17.84 million for FY2025, reflecting a strategic pivot towards core drug development and clinical advancement. The company secured key EU approvals and raised significant capital to support its neuro-immune modulatory pipeline.